Soluble PD-1 is Associated with Aberrant Regulation of T Cells Activation in Aplastic Anemia

REFERENCES

• Agata Y., Kawasaki A., Nishimura H., Ishida Y., Tsubata T., Yagita H., Honjo T. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 1996; 8: 765–772
   PubMed Web of Science ®Google Scholar
• Azuma T., Yao S., Zhu G., Flies A. S., Flies S. J., Chen L. B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells. Blood 2008; 111: 3635–3643
   PubMed Web of Science ®Google Scholar
• Dong H., Strome S. E., Matteson E. L., Moder K. G., Flies D. B., Zhu G., Tamura H., Driscoll C. L., Chen L. Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis. J. Clin. Invest. 2003; 111: 363–370
   PubMed Web of Science ®Google Scholar
• Fife B. T., Guleria I., Gubbels B. M., Eagar T. N., Tang Q., Bour-Jordan H., Yagita H., Azuma M., Sayegh M. H., Bluestone J. A. Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J. Exp. Med. 2006; 203: 2737–2747
   PubMed Web of Science ®Google Scholar
• He G. S., Zhou L., Wu D. P., Sun A. N., Miao M., Wang X. L., Chang W. R., Zhu Z. L., Jin Z. M., Qiu H. Y., et al. Role of CD28/CTLA-4 costimulators in immune pathophysiology of aplastic anemia. Zhonghua Xue Ye Xue Za Zhi 2007; 28: 590–593
   Google Scholar
• Ishida Y., Agata Y., Shibahara K., Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO. J. 1992; 11: 3887–3895
   PubMed Web of Science ®Google Scholar
• Kaufman D. W., Kelly J. P., Jurgelon J. M., Anderson T., Issaragrisil S., Wiholm B. E., Young N. S., Leaverton P., Levy M., Shapiro S. Drugs in the aetiology of agranulocytosis and aplastic anaemia. Eur. J. Haematol. 1996; 60: 23–30
   Google Scholar
• Keir M. E., Butte M. J., Freeman G. J., Sharpe A. H. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 2008; 26: 677–704
   PubMed Web of Science ®Google Scholar
• Li D. W., Yu J. F., Chen Y. J., Ma H. B., Wang Z. F., Zhu Y. B., Zhang X. G. Refolding and characterization of recombinant human GST-PD-1 fusion protein expressed in Escherichia coli. Acta. Biochim. Biophys. Sin. 2004; 36: 141–146
   Google Scholar
• Maciejewski J. P., Selleri C., Sato T., Anderson S., Young N. S. Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anemia. Br. J. Haematol. 1995; 91: 245–248
   PubMed Web of Science ®Google Scholar
• Matsui T., Kurokawa M., Kobata T., Oki S., Azuma M., Tohma S., Inoue T., Yamamoto K., Nishioka K., Kato T. Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases. J. Immunol. 1999; 162: 4328–4335
   Google Scholar
• Matsumoto K., Fukuyama S., Eguchi-Tsuda M., Nakano T., Matsumoto T., Matsumura M., Moriwaki A., Kan-o K., Wada Y., Yagita H., Shin T., et al. B7-DC induced by IL-13 works as a feedback regulator in the effector phase of allergic asthma. Biochem. Biophys. Res. Commun. 2008; 365: 170–175
   PubMed Web of Science ®Google Scholar
• Nielsen C., Ohm-Laursen L., Barington T., Husby S., Lillevang S. T. Alternative splice variants of the human PD-1 gene. Cell. Immunol 2005; 235: 109–116
   PubMed Web of Science ®Google Scholar
• Nishimura H., Agata Y., Kawasaki A., Sato M., Imamura S., Minato N., Yagita H., Nakano T., Honjo T. Developmentally regulated expression of the PD-1 protein on the surface of double-negative thymocytes. Int. Immunol. 1996; 8: 773–780
   PubMed Web of Science ®Google Scholar
• Nishimura H., Honjo T., Minato N. Facilitation of beta selection and modification of positive selection in the thymus of PD-1 deficient mice. J. Exp. Med. 2000; 191: 891–898
   PubMed Web of Science ®Google Scholar
• Nishimura H., Nose M., Hiai H., Minato N., Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999; 11: 141–151
   PubMed Web of Science ®Google Scholar
• Okazaki T., Tanaka Y., Nishio R., Mitsuiye T., Mizoguchi A., Wang J., Ishida M., Hiai H., Matsumori A., Minato N., et al. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat. Med. 2003; 9: 1477–1483
   PubMed Web of Science ®Google Scholar
• Shinohara T., Taniwaki M., Ishida Y., Kawaichi M., Honjo T. Structure and chromosomal localization of the human PD-1 gene (PDCD1). Genomics 1994; 23: 704–706
   PubMed Web of Science ®Google Scholar
• Wan B., Nie H., Liu A., Feng G., He D., Xu R., Zhang Q., Dong C., Zhang J. Z. Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis. J. Immunol. 2006; 177: 8844–8850
   PubMed Web of Science ®Google Scholar
• Wu H. J., Chen Y. J., Miao M., Zhang G. B., Hu Y. M., Ming Z. J., Zhang X. G. The preparation of soluble PD-1 ELISA kit and its application. Chinese J. Immunol. 2008; 24: 825–827
   Google Scholar
• Young N. S. Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia. Semin. Hematol. 2000; 37: 3–14
   PubMed Web of Science ®Google Scholar
• Young N. S., Abkowitz J. L., Luzzatto L. New insights into the pathophysiology of acquired cytopenias. Hematology. Am. Soc. Hematol. Educ. Program. 2000; 2000: 18–38
   Google Scholar